RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY. (12th June 2019) - Lugtenburg, P.; de Nully Brown, P.; van der Holt, B.; d'Amore, F.; Koene, H.; de Jongh, E.; Fijnheer, R.; Loosveld, O.; Böhmer, L.; Pruijt, H.; Verhoef, G.; Hoogendoorn, M.; et al.